Zimmer Biomet is a musculoskeletal healthcare company. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues.

Type
Public
HQ
Warsaw, US
Founded
1927
Size (employees)
18,500 (est)
Zimmer Biomet was founded in 1927 and is headquartered in Warsaw, US
Report incorrect company information

Key People/Management at Zimmer Biomet

Bryan Hanson

Bryan Hanson

President and Chief Executive Officer
Aure Bruneau

Aure Bruneau

Group President, Spine, CMF, Thoracic and Surgery Assisting Technology
Chad Phipps

Chad Phipps

Senior Vice President, General Counsel and Secretary
Daniel Williamson

Daniel Williamson

Group President, Joint Reconstruction
Sang Yi

Sang Yi

President, Asia Pacific
Tony Collins

Tony Collins

Vice President, Corporate Controller and Chief Accounting Officer
Show more

Zimmer Biomet Office Locations

Zimmer Biomet has an office in Warsaw
Warsaw, US (HQ)
345 E Main St
Warsaw, US
1800 W Center St
Show all (2)
Report incorrect company information

Zimmer Biomet Financials and Metrics

Zimmer Biomet Revenue

Embed Graph
Zimmer Biomet's revenue was reported to be $7.68 b in FY, 2016 which is a 28.1% increase from the previous period.
USD

EBIT (Q1, 2018)

305 m

Market capitalization (11-Jul-2018)

23.2 b

Closing share price (11-Jul-2018)

114.2
Zimmer Biomet's current market capitalization is $23.2 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

4.6 b4.7 b6 b7.7 b

Revenue growth, %

1%28%28%

Cost of goods sold

1.3 b1.2 b1.8 b2.4 b

Gross profit

3.3 b3.4 b4.2 b5.3 b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

1.1 b1.2 b1.2 b1.1 b1.1 b1.2 b176.2 m1.9 b1.9 b1.8 b2 b2 b1.8 b

Cost of goods sold

328.8 m305.4 m333.2 m298.3 m278.7 m290.5 m552.1 m635.2 m640.1 m479.3 m512.9 m527.7 m

Gross profit

745.5 m856.1 m849.7 m807.7 m855.7 m877.1 m(375.9 m)1.3 b1.3 b1.4 b1.5 b1.4 b

Gross profit Margin, %

69%74%72%73%75%75%(213%)67%67%74%74%73%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

1.1 b1.1 b1.5 b634.1 m

Accounts Receivable

936.6 m912.1 m1.4 b1.6 b

Prepaid Expenses

107.1 m193.7 m538.4 m465.7 m

Inventories

1.1 b1.2 b2.3 b2 b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Cash

917.4 m882.7 m968.7 m967.3 m8.8 b1.4 b1.5 b996.8 m976.3 m475.3 m1 b450 m480.8 m

Accounts Receivable

869.8 m1.5 b1.4 b1.6 b1.6 b1.6 b1.6 b1.4 b

Prepaid Expenses

246.8 m551.7 m475.8 m420.7 m518.9 m535.8 m463.3 m527.2 m

Inventories

1.1 b1.1 b1.1 b1.2 b1.2 b2.4 b2.4 b2.1 b2 b2.1 b2 b2 b2.1 b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

759.2 m719 m146.2 m304.6 m

Depreciation and Amortization

358.5 m375.8 m712.4 m1 b

Inventories

(128.4 m)(154.1 m)(205.4 m)76.4 m

Accounts Payable

38.3 m120.1 m(263.1 m)28.7 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

154.1 m221.1 m176.1 m165.3 m176.8 m18.6 m19.5 m105.8 m77 m234.9 m299.3 m483.4 m98.8 m

Depreciation and Amortization

89 m188.6 m428.1 m246.9 m499.2 m787.3 m267.6 m531.7 m

Inventories

(62.2 m)(149.9 m)(196.5 m)38.3 m60.2 m44.2 m(11.5 m)(68.8 m)2.1 b

Accounts Payable

(149.5 m)95.8 m(251.5 m)(120.7 m)(141.9 m)(76 m)(137 m)(203.7 m)327.1 m
Show all financial metrics

Zimmer Biomet Operating Metrics

FY, 2014FY, 2015FY, 2016FY, 2017

Countries

100 100 100 100

Patents and Patent Applications

4.50 k7 k8 k8 k
Show all operating metrics

Zimmer Biomet Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Accelero Health Partners
Aut Inveniam Aut Faciam Pty. Ltd.
Beijing Montagne Medical Device Co. Ltd.
Biomet
Biomet 3i
Biomet 3i Australia Pty. Ltd.
Biomet 3i Belgium N.V.
Biomet 3i Benelux Holdings N.V.
Biomet 3i do Brasil Comercio de Aparelhos Medicos Ltda.
Biomet 3i Portugal Lda
Show more

Zimmer Biomet Revenue Breakdown

Embed Graph

Zimmer Biomet revenue breakdown by business segment: 8.6% from Spine & CMF, 5.6% from Dental, 21.4% from S.E.T, 24.3% from Hips, 35.8% from Knees and 4.3% from Other

Report incorrect company information

Zimmer Biomet Online and Social Media Presence

Embed Graph
Report incorrect company information

Zimmer Biomet News and Updates

Viscosupplementation Market by value & volume 2018-2025 | Key Players : Zimmer Biomet, Meda, Ferring

HTF MI published a new industry research that focuses on Viscosupplementation market and delivers in-depth market analysis and future prospects of Global Viscosupplementation market. Posted via Industry Today. Follow us on Twitter @IndustryToday

Zimmer Biomet Holdings Announces Audio Webcast and Conference Call of Second Quarter 2018 Results

WARSAW, Ind., June 20, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter sales and earnings conference call will be broadcast over the Internet on Friday, July 27, 2018, at 8:30 a.m. Eastern Time.  A news release detailing the quarterl...

Global Orthopedic Splints Market 2017: Key Players – DJO, DeRoyal, Zimmer Biomet, ORFIT, Mika Medical

WiseGuyReports.com adds “Orthopedic Splints Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information

Zimmer Biomet Company Life and Culture

Report incorrect company information